The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: A 1-year follow up study

Cognitive dysfunctions (as in memory, attention and executive function) have been recognized as fundamental features of schizophrenia. Executive dysfunction is a major obstacle to functional outcome, community functioning and rehabilitation success and it is crucial to assess the effects of so-calle...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Schizophrenia research 2005-12, Vol.80 (1), p.99-106
Hauptverfasser:	Rémillard, Sophie, Pourcher, Emmanuelle, Cohen, Henri
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Adult and adolescent clinical studies Antipsychotic Agents - pharmacology Antipsychotic Agents - therapeutic use Biological and medical sciences Brain - drug effects Brain - physiopathology Cognition - drug effects Cognition Disorders - diagnosis Cognition Disorders - etiology Double-Blind Method Executive function Female Follow-Up Studies Haloperidol Haloperidol - pharmacology Haloperidol - therapeutic use Humans Long-term treatment Male Medical sciences Middle Aged Neuropharmacology Neuropsychological Tests Pharmacology. Drug treatments Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Psychoses Risperidone Risperidone - pharmacology Risperidone - therapeutic use Schizophrenia Schizophrenia - complications Schizophrenia - drug therapy Schizophrenia - physiopathology Symptomatology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!